Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case · The Wall Street Journal

In This Article:

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor. Reckitt shares fell about 1.7% in London, while Abbott shares dropped nearly 3% in U.S. afternoon trading. Last October a jury had found the companies were not liable in a state lawsuit that alleged the companies’s infant formula products caused necrotizing enterocolitis, a debilitating intestinal disease that can cause bloating, vomiting and diarrhea in premature babies.